Therapeutic Role of Polyphenol Extract from Prunus cerasifera Ehrhart on Non-Alcoholic Fatty Liver
Open Access
Abstract
Prunus cerasifera Ehrhart (P. cerasifera) flourishes uniquely in the arid landscapes of Xinjiang, China. Preliminary studies have revealed the therapeutic potential of its polyphenol extract (PPE) in mitigating liver lipid accumulation in mice fed a high-fat diet. We established a mouse model that was subjected to a continuous high-fat diet for 24 weeks and administered PPE to investigate the effects of PPE on cholesterol and BA metabolism in NAFLD mice. The results showed that PPE administration (200 and 400 mg/kg/day, BW) led to a reduction in liver TC, an increase in liver T-BAs, and normalization of the disrupted fecal BA profile. Concurrently, it decreased levels of lipotoxic BAs and inhibited hepatic cholesterol synthesis (evidenced by reduced HMGCR activity) and intestinal cholesterol absorption (indicated by lower ACAT2 levels) while enhancing intestinal cholesterol efflux (via LXRα, ABCA1, ABCG5, and ABCG8) and stimulating hepatic BA synthesis (CYP7A1, CYP27A1) and secretion (BSEP). PPE thus led to a significant reduction in lipotoxic BAs metabolized by gut microbiota and a downregulation of the BA secretion pathway under its influence. Our findings reveal the therapeutic effect of PPE on NAFLD mice via regulating cholesterol and BA metabolism, providing a theoretical basis for exploring the potential functions of P. cerasifera.Keywords
Funding Information
- Xinjiang Uygur Autonomous Region university research project (XJEDU2023J031, 2022D01A100)
- Natural Science Foundation Project of Xinjiang Uygur Autonomous Region (XJEDU2023J031, 2022D01A100)
This publication has 39 references indexed in Scilit:
- Statins for Prevention of Cardiovascular Disease in AdultsJAMA, 2016
- The role of the gut microbiota in NAFLDNature Reviews Gastroenterology & Hepatology, 2016
- Resveratrol Attenuates Trimethylamine- N -Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut MicrobiotamBio, 2016
- Repression of the Nuclear Receptor Small Heterodimer Partner by Steatotic Drugs and in Advanced Nonalcoholic Fatty Liver DiseaseMolecular Pharmacology, 2015
- Bile Acid-Mediated Control of Liver TriglyceridesSeminars in Liver Disease, 2013
- Bile Salt Excretory PumpJournal of Pediatric Gastroenterology and Nutrition, 2006
- Bile salt biotransformations by human intestinal bacteriaJournal of Lipid Research, 2006
- Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human DiseasesCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2005
- Function and Regulation of Hydroxylases Involved in the Bile Acid Biosynthesis PathwaysSeminars in Liver Disease, 1992
- The Metabolism of Chenodeoxycholic Acid to β‐Muricholic Acid in Rat LiverEuropean Journal of Biochemistry, 1983